Form 6-K

 

 

FORM 6-K

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Participation in Production of Chlor-Alkali with Dow

Chemical in Texas, USA

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of July 1, 2010

Commission File Number 09929

 

 

Mitsui & Co., Ltd.

(Translation of registrant’s name into English)

2-1, Ohtemachi 1-chome Chiyoda-ku, Tokyo 100-0004 Japan

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F      X            Form 40-F              

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):              

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):              

 

 

 


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 1, 2010

 

MITSUI & CO., LTD.
By:  

/s/ Junichi Matsumoto

Name:   Junichi Matsumoto
Title:   Executive Vice President
  Chief Financial Officer


July 1, 2010

For Immediate Release:

To Whom It May Concern

Mitsui & Co., Ltd.

Participation in Production of Chlor-Alkali with Dow Chemical in Texas, USA

Mitsui & Co., Ltd. (“Mitsui”) announced today that Mitsui and The Dow Chemical Company (“Dow”) entered into an agreement to form a new joint venture company at 50:50 share for constructing, owning and operating a new Chlor-Alkali facility in Freeport, Texas, USA, on July 1, 2010 (New York time). Mitsui’s investment in this project is expected to be approximately USD 140 million. Mitsui is also discussing to arrange project finance separately for additional funds with related financial institutions.

Outline of Joint Venture Agreement

 

Activities    Production and Sales of Caustic Soda and Chlorine
Investment Ratio   

Mitsui 100% owned US subsidiary : 50%

 

Dow : 50%

Form of Joint Venture    LLC*
Mitsui’s Amount of Investment    Approx. 140 million U.S. dollars

 

* LLC (Limited Liability Company): A form of business entity allowed by many jurisdictions in the United States, which allows for a company to be formed with limited liability and receive partnership tax treatment.

 

1


The joint venture agreement is conditional upon regulatory approval by the relevant governmental authorities. Mitsui and Dow are targeting to complete the deal by the end of August 2010.

Caustic Soda and Chlorine, which are basic raw materials of various chemical products and processes, are produced through electrolysis of brine. The highly-advanced and world-scale membrane chlor-alkali facility in the new joint venture will fulfill stable and competitive production of Caustic Soda and Chlorine.

Currently Mitsui operates the sales and marketing business of Chlorine derivatives around the world including Ethylene Dichloride (“EDC”) which Mitsui is among those with the largest share of merchant market. The Chlorine produced by the new joint venture will be converted to EDC by Dow through a tolling conversion arrangement and will enhance Mitsui’s stable supply of Caustic Soda and EDC to the marketplace.

This strategic partnership forming the new joint venture between Mitsui and Dow brings Mitsui an opportunity not only to enter into a significant manufacturing venture in the field of strategic importance but also to enhance the strategic business relationship with Dow.

In April 2009, Mitsui newly established the Chlor-Alkali Division consolidating all of its chlor-alkali related businesses such as Salt, Alkali products, EDC and Vinyl Chloride Monomer, Polyvinyl Chloride Resin, and Polyurethanes raw material in order to create synergy among them and deliver further value to our customers.

 

Attachment:    Details of Project/ Profile of Dow/ Project Scheme/
   Chlor-Alkali Product Flow Chart

 

2


For further information, please contact:

 

Mitsui & Co., Ltd.   

Investor Relations Division

  

Corporate Communications Division

Telephone: +81-3-3285-7910

  

Telephone: +81-3-3285-7540

Notice: This press release includes forward-looking statements about Mitsui. These forward-looking statements are based on the current assumptions and beliefs of Mitsui in light of the information currently available to it, and involve known and unknown risks, uncertainties and other factors. Such risks, uncertainties and other factors may cause Mitsui’s actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements. The risks, uncertainties and other factors referred to above include, but are not limited to, those contained in Mitsui’s latest annual report on Form 20-F, which has been filed with the U.S. Securities and Exchange Commission. This press release is published in order to publicly announce specific facts stated above, and does not constitute a solicitation of investments or any similar act inside or outside of Japan, regarding the shares, bonds or other securities issued by us.

 

3


<Attachment>

1. Details of Project

 

Location    Freeport, Texas, USA
Start Operation    Mid - 2013
Production Capacity    Caustic Soda : Approx. 880,000 dmt
(Yearly basis)    Chlorine : Approx. 800,000 mt

2. Profile of Dow

 

Formal name    The Dow Chemical Company
Representative    Andrew Liveris, Chairman & CEO
Location of HQ    Midland, Michigan, USA
Stock exchange listings    NYSE : DOW
Employees**    Approx. 52,000
Main activities    Manufacturing and marketing of plastics, chemicals and agricultural products
Consolidated net sales**    Approx. 45 billion U.S. dollars
Consolidated total asset**    Approx. 65.9 billion U.S. dollars

 

** As of December, 2009

 

4


3. Project Scheme

LOGO

4. Chlor-Alkali Product Flow Chart

LOGO

 

5